Real-time enrollment status for this thoracic neoplasms, lung diseases, small cell lung carcinoma clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 12:29 PM UTC
| NCT Number | NCT07407933 |
| Recruiting Status | Recruiting |
| Condition | Thoracic Neoplasms, Lung Diseases, Small Cell Lung Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 118 participants |
| Active Locations | 5 sites in the US |
| Sponsor | MediLink Therapeutics (Suzhou) Co., Ltd. |
| Last Updated on CT.gov | September 17, 2026 (4 weeks ago) |
As of October 15, 2026: Clinical trial NCT07407933 is currently recruiting participants. This phase1 study for thoracic neoplasms, lung diseases, small cell lung carcinoma is actively seeking new participants at 5 locations across the United States. The study is sponsored by MediLink Therapeutics (Suzhou) Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07407933 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07407933 was last updated 4 weeks ago (September 17, 2026). HelloStudys verifies this status automatically.